Intelligence Platform
Patents
Browse 222 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11332746
Compounds and methods for reducing LRRK2 expression
granted patentUS 11319536
Modulating apolipoprotein (a) expression
granted patentUS 11312964
Compositions and methods for modulating growth hormone receptor expression
granted patentUS 11312962
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted patentUS 11299736
Conjugated antisense compounds and their use
granted patentUS 11299737
Compounds and methods for modulating SMN2
granted patentUS 11293025
Compositions and methods for modulating Ataxin 3 expression
granted patentUS 11241451
Modulators of IRF4 expression
granted patentUS 11236141
Targeted mutant interferon-beta and uses thereof
granted patentUS 11236166
CD8 binding agents
granted patentUS 11236335
Selective antisense compounds and uses thereof
granted patentUS 11236339
Modulation of GYS1 expression
granted patentUS 11230712
Compounds and methods for reducing SNCA expression
granted patentUS 11225664
Modulation of angiopoietin-like 3 expression
granted patentUS 11214803
Modulators of YAP1 expression
granted patentUS 11208650
Modulators of IRF5 expression
granted patentUS 11197884
Modulation of the notch signaling pathway for treatment of respiratory disorders
granted patentUS 11193128
Compositions for modulating expression of C9ORF72 antisense transcript
granted patentUS 11155815
Compositions and methods for modulating Tau expression
granted patentUS 11136577
Methods and compositions for inhibiting PMP22 expression
granted patentUS 11129844
Compositions and methods for modulating MECP2 expression
granted patentUS 11116843
Conjugated antisense compounds and their use
granted patentUS 11118183
Modulation of angiopoietin-like 3 expression
granted patentUS 11111494
Compositions for modulating Ataxin 2 expression
granted